Related Experiment Video
Updated: May 13, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Subversion of mRNA degradation pathways by EWSR1::FLI1 represents a therapeutic vulnerability in Ewing sarcoma
Bartimée Galvan1,2, Loïc Ongena1, Jonathan Bruyr1
1Laboratory of Gene Expression and Cancer, GIGA Institute, University of Liège (ULiège), Liège, Belgium.
Abstract:
Many cancers are defined by gene fusions that frequently encode oncogenic transcription factors (TFs), such as EWSR1::FLI1 in Ewing sarcoma (EwS). Here, we report that independently to its canonical roles in transcription, EWSR1::FLI1 also functions as an mRNA decay factor, reshaping mRNA stability in EwS. This function participates in EWSR1::FLI1 tumorigenicity and involves interactions of EWSR1::FLI1 with the CCR4-NOT deadenylation complex via its EWSR1-derived low-complexity domain and with the RNA-binding protein HuR/ELAVL1 via its FLI1-derived region. Strikingly, we find that EWSR1::FLI1-mediated mRNA decay antagonizes the normal mRNA protective function of HuR and renders EwS cells highly sensitive to HuR inhibition. Our findings uncover a post-transcriptional function of EWSR1::FLI1 and suggest that targeting mRNA stability mechanisms may offer therapeutic opportunities for EwS.
Insights
EWSR1::FLI1, a transcription factor in Ewing sarcoma, also promotes cancer by accelerating mRNA decay. This newly found function makes cancer cells vulnerable to therapies targeting HuR.
Area of Science:
- Molecular Biology
- Cancer Research
- Gene Regulation
Background:
- Gene fusions, such as EWSR1::FLI1, are hallmarks of many cancers, including Ewing sarcoma (EwS).
- EWSR1::FLI1 is known to function as an oncogenic transcription factor (TF).
- The precise mechanisms by which EWSR1::FLI1 drives tumorigenesis are still being uncovered.
Purpose of the Study:
- To investigate non-canonical functions of EWSR1::FLI1 beyond its role as a transcription factor.
- To elucidate the role of EWSR1::FLI1 in regulating mRNA stability in Ewing sarcoma.
- To identify potential therapeutic strategies targeting EWSR1::FLI1-mediated pathways.
Main Methods:
- Investigated EWSR1::FLI1's function as an mRNA decay factor in EwS cells.
- Analyzed interactions of EWSR1::FLI1 with the CCR4-NOT deadenylation complex and HuR/ELAVL1.
- Assessed the impact of EWSR1::FLI1-mediated mRNA decay on cellular sensitivity to HuR inhibition.
Main Results:
- EWSR1::FLI1 functions as an mRNA decay factor, independent of its transcriptional activity.
- EWSR1::FLI1 interacts with the CCR4-NOT complex and the RNA-binding protein HuR.
- EWSR1::FLI1-induced mRNA decay antagonizes HuR's protective function, sensitizing EwS cells to HuR inhibition.
Conclusions:
- EWSR1::FLI1 possesses a novel post-transcriptional function in regulating mRNA stability.
- This function contributes to EWSR1::FLI1-driven tumorigenesis in Ewing sarcoma.
- Targeting mRNA stability pathways, particularly HuR, presents a potential therapeutic avenue for EwS.
Related Concept Videos
Nuclear Export of mRNA
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Experimental RNAi
Regulation of the Unfolded Protein Response

